Zhejiang China Commodities City Group's revenue exceeds 15 billion in 2024, with registered purchasing merchants surpassing 4.8 million｜Interpretations.

① Zhejiang China Commodities City Group's revenue last year was 15.737 billion yuan, with a year-on-year growth of 39.27%. Although the growth rate has slowed compared to the previous year, the total value is the highest ever. ② The increase in profits is mainly due to the growth of new businesses this period, such as market Operations, Chinagoods, and Yi payment. ③ The number of registered buyers on the Chinagoods platform has exceeded 4.8 million, and the Net income of its operating entities has increased by 102.05% year-on-year.

cls.cnMar 26 08:53 ET

Accelerating store closures and adjustments, globally recruiting a CEO, Yonghui has officially entered the "Ye Guofu Era."

Clear out the inventory stores in two years.

wallstreetcnMar 19 05:34 ET

Yonghui Shareholder Meeting: 2k-3k medium and small supermarkets are a trend for transformation, the "Fat Donglai model + quality retail" is the future of supermarkets in China.

CEO of MINISO, Ye Guofu, stated that we are currently on the eve of a major reshuffle in offline supermarkets. In the future, 1-2 national supermarket leaders will emerge, with high-quality products and services along with stores and distribution centers spread across the country forming the foundation of future consumer demand. Small and medium-sized supermarkets of 2,000-3,000 square meters are the trend for transformation. Yonghui will adhere to the Fat Donglai model and the strategic direction of quality retail, which represents the future of supermarkets in China.

wallstreetcnMar 18 04:30 ET

Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the

① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.

cls.cnMar 2 21:09 ET

It is estimated that in 2024, after deducting non-recurring items, the loss will be reduced by more than 30%. Special Treat Bubugao plans to complete the supermarket store adjustments before August this year | Interpretations

① Special Treat Bubugao expects to achieve a net income of 0.86 billion to 1.26 billion yuan in 2024, turning losses into profits year-on-year; after deducting non-recurring items, the net income is expected to be -0.76 billion to -1.12 billion yuan, which is a reduction in loss of 31.35% to 53.42% year-on-year. ② Special Treat Bubugao plans to complete the adjustment of supermarket stores by August this year and aims to launch its own brand commodity in Q1.

cls.cnJan 22 10:58 ET

Is the restructuring the peak? Guangzhou Grandbuy's performance continues to decline as Bank of China Investment continuously makes "precise" Shareholding reductions | Quick read announcement.

① In the past 11 trading days, Guangzhou Grandbuy has hit the limit up six times, while China Merchants Investment has continuously and "precisely" reduced its shareholding by nearly 3% since January 3. ② After achieving peak performance through asset restructuring in 2021, Guangzhou Grandbuy has shown poor performance in recent years, and the major shareholders' successive reductions may have other considerations.

cls.cnJan 16 10:47 ET